NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
Early pneumonia diagnosis and treatment during COVID-19 pandemic. Is there a feasible strategy to accomplish this?

Gómez-Gómez, Alejandro1; Gómez-Escanamé, María José1; Sánchez-Ramos, Lidya2; Noyola, Daniel E1





2020, Number 4

2020; 79 (4)






ABSTRACT

KEYWORDS

.

REFERENCES

  1. Comité Estatal para la Seguridad en Salud. Reportes del 1 al 20 de agosto de 2020. Gobierno del Estado de San Luis Potosí.

  2. St. John AL, Rathore APS. Early insights into immune responses during COVID-19. J Immunol. 2020;205(3):555-564. Available in: https://doi.org/10.4049/jimmunol.2000526

  3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. Available in: https://doi.org/10.1056/nejmoa2002032

  4. Quah P, Li A, Phua J. Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature. Crit Care. 2020;24(1):285. Available in: https://doi.org/10.1186/s13054-020-03006-1

  5. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGuinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with Covid-19 in the New York City area. JAMA. 2020;323(20):2052-2059. Available in: https://doi.org/10.1001/jama.2020.6775

  6. Hubmayr RD, Kallet RH. Understanding pulmonary stress-restrain relationships in severe ARDS and its implications for designing a safer approach to setting the ventilator. Respir Care. 2018;63(2):219-226. Available in: https://doi.org/10.4187/respcare.05900

  7. Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438-442. Available in: https://doi.org/10.1164/rccm.201605-1081cp

  8. Yoshida T, Grieco DL, Brochard L, Fujino Y. Patient self-inflicted lung injury and positive end-expiratory pressure for safe spontaneous breathing. Curr Opin Crit Care. 2020;26(1):59-65. Available in: https://doi.org/10.1097/mcc.0000000000000691

  9. Grieco DL, Menga LS, Eleuteri D, Antonelli M. Patient self-inflicted lung injury: implications for acute hypoxemic respiratory failure and ARDS patients on non-invasive support. Minerva Anestesiol. 2019;85(9):1014-1023. Available in: https://doi.org/10.23736/s0375-9393.19.13418-9

  10. Madahar P, Beitler JR. Emerging concepts in ventilation-induced lung injury. F1000Res. 2020;9:F1000 Faculty Rev-222. Available in: https://doi.org/10.12688/f1000research.20576.1

  11. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med. 2020;202(3):356-360. Available in: https://doi.org/10.1164/rccm.202006-2157cp

  12. Pérez-Padilla JR, Thirión-Romero II, Aguirre-Pérez T, Rodríguez-Llamazares S. ¿Qué tan silenciosa es la hipoxemia en COVID-19? Neumol Cir Torax. 2020;79(2):69-70. Disponible en: https://dx.doi.org/10.35366/94629

  13. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943. Available in: https://doi.org/10.1001/jamainternmed.2020.0994

  14. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110-118. Available in: https://doi.org/10.1016/j.jaci.2020.04.006

  15. Suleyman G, Fadel RA, Malette KM, Hammond C, Adbulla H, Entz A, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open. 2020;3(6):e20122270. Available in: https://doi.org/10.1001/jamanetworkopen.2020.12270

  16. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microb Infect. 2020;26(6):767-772. Available in: https://doi.org/10.1016/j.cmi.2020.04.012

  17. Sun Q, Qiu H, Huang M, Yang Y. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care. 2020;10(1):33. Available in: https://doi.org/10.1186/s13613-020-00650-2

  18. Ihle-Hansen H, Berge T, Tveita A, Rønning EJ, Ernø PE, Andersen EL, et al. Covid-19: symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital. Tidsskr Nor Laegeforen. 2020;140(7). Available in: https://doi.org/10.4045/tidsskr.20.0301

  19. Ciceri F, Castagna A, Rovere-Querini P, De Cobelli F, Ruggeri A, Galli L, et al. Early predictors of clinical outocomes of COVID-19 outbreak in Milan Italy. Clin Immunol. 2020;217: 108509. Available in: https://doi.org/10.1016/j.clim.2020.108509

  20. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020;10.1002/jmv.26050. Available in: https://doi.org/10.1002/jmv.26050

  21. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):762-774. Available in: https://doi.org/10.1001/jama.2016.0288

  22. Lim WS, van der eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382. Available in: https://doi.org/10.1136/thorax.58.5.377

  23. Liu JL, Xu F, Zhou H, Wu XJ, Shi LX, Lu RQ, et al. Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency. Sci Rep. 2016;6:22911. Available in: https://doi.org/10.1038/srep22911

  24. Charles PGP, Wolfe R, Whitby M, Fine MJ, Fuller AJ, Stirling R, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008;47(3):375-384. Available in: https://doi.org/10.1086/589754

  25. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-250. Available in: https://doi.org/10.1056/nejm199701233360402

  26. Gobierno de México. Flujograma de atención médica para COVID-19 en el primer nivel de atención. [Fecha de consulta: 16 de agosto de 2020] Disponible en: https://coronavirus.gob.mx/wp-content/uploads/2020/04/Flujograma_Atencion_Primer_Nivel_13042020.pdf

  27. Gobierno de México, IMSS. Algoritmos interinos para la atención del COVID-19. 31 julio 2020. [Fecha de consulta: 16 de agosto de 2020] Disponible en: http://educacionensalud.imss.gob.mx/es/system/files/Algoritmos_interinos_COVID19_CTEC.pdf.

  28. Elizalde González JJ, Fortuna Custodio JA, Luviano García JA, Mendoza Romero VM, Mijangos Méndez JC, Olivares Durán EM, et al. Guía COVID-19 para la atención del paciente crítico con infección por SARS-CoV-2 Colegio Mexicano de Medicina Crítica. Med Crit. 2020;34(1):7-42. Disponible en: https://dx.doi.org/10.35366/93279

  29. Siordia Jr JA. Epidemiology and clinical features of COVID-19: a review of current literature. J Clin Virol. 2020;127:104357. Available in: https://doi.org/10.1016/j.jcv.2020.104357

  30. BMJ Best Practice. Enfermedad de coronavirus 2019 (COVID-19). Agosto 10, 2020. [Fecha de consulta: 18 de agosto de 2020] Disponible en: https://bestpractice.bmj.com/topics/es-es/3000168.

  31. Romero-Hernández S, Saavedra Uribe J, Zamarrón López EI, Pérez-Nieto OR, Figueroa Uribe AF, Guerrero Gutiérrez MA, et al. Protocolo de atención para COVID-19 (SARS-CoV-2) de la Sociedad Mexicana de Medicina de Emergencias. 2020. Available in: https://doi.org/10.13140/RG.2.2.16460.97922

  32. Royal College of Physicians. National Early Warning Score (NEWS) 2: Standardizing the assessment of acute-illness severity in the NHS. Updated report of a working party. London: RCP; 2017.

  33. UK Nacional Health Service. NHS guidance for pulse oximetry to detect early deterioration of patients with COVID-19 in primary and community care setting. [Access date: 2020 August 16] Available in: https://www.england.nhs.uk/coronavirus/publication/pulse-oximetry-to-detect-early-deterioration-of-patients-with-covid-19-in-primary-and-community-care-settings/.

  34. Vitacca M, Nava S, Santus P, Harari S. Early consensus management for non-ICU acute respiratory failure SARS-CoV-2 emergency in Italy: from ward to trenches. Eur Respir J. 2020;55(5):2000632. Available in: https://doi.org/10.1183/13993003.00632-2020

  35. Vega ML, Sirotti C, Montiel G, Sandoval GJL, Baz EM, Cohen TM, et al. AAMR/Departamentos Medicina Crítica/Sueño ALAT. Recomendaciones para el manejo invasivo y no invasivo de la insuficiencia respiratoria hipoxémica por COVID-19. Respirar. 2020;12(1): Separata (3)1-30.

  36. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico. J Clin Endocrinol Metab. 2020;105(8):dgaa346. Available in: https://doi.org/10.1210/clinem/dgaa346

  37. Ministerio de Salud Colombia, OMS, OPS. Uso e interpretación de la oximetría de pulso. Convenio 519 de 2015. Bogotá. D.C.: 2016. [Fecha de consulta: 20 de agosto de 2020] Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/uso-interprtn-oximetria-pulso.pdf

  38. Vázquez García JC, Pérez-Padilla R. Valores gasométricos estimados para las principales poblaciones y sitios a mayor altitud en México. Rev Inst Nal Enf Resp Mex. 2000;13(1):6-13.

  39. Hess DR. Pulse oximetry: Beyond SpO2. Respir Care. 2016;61(12):1671-1680. Available in: https://doi.org/10.4187/respcare.05208

  40. Organización Panamericana de la Salud. Aspectos técnicos y regulatorios sobre el uso de oxímetros de pulso en el monitoreo de pacientes con COVID-19. 7 agosto 2020. [Fecha de consulta: 22 de agosto de 2020] Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52551/OPSHSSMTCOVID-19200029_spa.pdf?sequence=1&isAllowed=y.

  41. Manual de Operaciones y atención clínica. Fuente: datos de la Unidad Temporal COVID-19, UTC-19 Citibanamex.

  42. Quaresima V, Ferrari M. More in pulse oximetry for monitoring patients with COVID-19 at home. Ann Am Thorac Soc. 2020. Available in: https://doi.org/10.1513/annalsats.202006-701le

  43. Koeckerling D, Barker J, Mudalige NL, Oyefeso O, Pan D, Pareek M, et al. Awake prone positioning in COVID-19. Thorax. 2020;75(10):833-834. doi: 10.1136/thoraxjnl-2020-215133.

  44. Thompson AE, Ranard BL, Wei Y, Jelic S. Prone positioning in awake, nonintubated patients with COVID-19 hypoxemic respiratory failure. JAMA Intern Med. 2020:e203030. Available in: https://doi.org/10.1001/jamainternmed.2020.3030

  45. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. [Access date: 2020 September 25] Available in: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf.

  46. RECOVERY Collaborative group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19-Preliminary report. N Engl J Med. 2020;NEJMoa2021426. Available in: https://doi.org/10.1056/nejmoa2021436

  47. Randomised evaluation of COVID-19 therapy (RECOVERY). [Access date: 2020 September 20] Available in: https://www.recoverytrial.net/files/recovery-protocol-v7-0-2020-06-18.pdf.

  48. A study to evaluate the safety and efficacy of tocilizumab in patients with severe COVID-19 pneumonia (COVACTA). [Access date: 2020 September 20] Available in: https://clinicaltrials.gov/ct2/show/NCT04320615.

  49. Adaptive COVID-19 treatment trial 2 (ACTT-2). [Access date: 2020 September 18] Available in: https://clinicaltrials.gov/ct2/show/NCT04401579.


2020, Number 4

2020; 79 (4)